000 | 01109 a2200313 4500 | ||
---|---|---|---|
005 | 20250517095026.0 | ||
264 | 0 | _c20170705 | |
008 | 201707s 0 0 eng d | ||
022 | _a1750-7448 | ||
024 | 7 |
_a10.2217/imt-2016-0013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPaul, Barry | |
245 | 0 | 0 |
_aCheckpoint inhibition for colorectal cancer: progress and possibilities. _h[electronic resource] |
260 |
_bImmunotherapy _c06 2016 |
||
300 |
_a693-704 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers, Pharmacological _xmetabolism |
650 | 0 | 4 |
_aColorectal Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aCostimulatory and Inhibitory T-Cell Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aO'Neil, Bert H | |
700 | 1 | _aMcRee, Autumn J | |
773 | 0 |
_tImmunotherapy _gvol. 8 _gno. 6 _gp. 693-704 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/imt-2016-0013 _zAvailable from publisher's website |
999 |
_c26036667 _d26036667 |